Pharmaceutical Solid Dose (Commercial Dose) Manufacturing in Contract Marketing

Analyst Comment

Trump tariffs drive pharma manufacturing to US but risk inflation and disruption

Pressure may grow on companies to repatriate production, raising production costs and potentially medicine prices too.

GlobalData Healthcare

Buyer's Guides

Oral Solid Dosage Manufacturing Companies, Equipment and Market

Buyer's Guides

Oral Solid Dose Manufacturing Companies in the Pharmaceutical Industry

News

Biocon Generics purchases Eywa’s manufacturing facility in US

Sign up to the newsletter: In Brief

I would also like to subscribe to:

Pharma Technology Focus : Focus (monthly)

Thematic Take (monthly)

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close

Sections

Sections

Sections

Sections

Sections

Trump tariffs drive pharma manufacturing to US but risk inflation and disruption

Oral Solid Dosage Manufacturing Companies, Equipment and Market

Oral Solid Dose Manufacturing Companies in the Pharmaceutical Industry

Biocon Generics purchases Eywa’s manufacturing facility in US

Digital health and digital therapeutics (DTx) services and providers for the pharmaceutical industry

Leading Artificial Intelligence (AI) Companies in Pharma

Sign up for our daily news round-up!

Sign up to the newsletter: In Brief